What Researchers Did
Researchers conducted a systematic review to outline the therapeutic mechanisms and review the efficacy of hyperbaric oxygen therapy for clinical problems relevant to plastic and reconstructive surgery.
What They Found
The review found that systematic reviews and randomized clinical trials support hyperbaric oxygen use for refractory diabetic wound-healing and radiation injuries. Evidence from animal studies and a small number of clinical trials also supports its use for compromised flaps, grafts, and ischemia-reperfusion disorders, though more research is needed.
What This Means for Canadian Patients
Canadian patients suffering from refractory diabetic wounds or radiation injuries may find hyperbaric oxygen therapy to be a beneficial treatment option. For other conditions like compromised flaps or grafts, its utility is still being investigated, suggesting it may not be a standard treatment yet.
Canadian Relevance
This systematic review does not have a direct Canadian connection.
Study Limitations
The study notes that further research is required to clarify the clinical utility of hyperbaric oxygen therapy for some disorders and to refine patient selection criteria for improved cost-efficacy.